Get started
Work

The impact of COVID-19 on a national sample of US adults with food allergy

Year: 2022
Type: article
DOI: 10.1016/j.jaip.2022.07.036
Authors: Christopher Warren, Janell Sherr, Sayantani Sindher, Kari C. Nadeau, Thomas B. Casale, Dana Ward, Ruchi Gupta, R. Sharon Chinthrajah
Language: English
Field: Medicine
Open Access status: bronze
Funders: U.S. Environmental Protection Agency, Parker Foundation, Astellas Pharma US, AstraZeneca, GlaxoSmithKline, Novartis, Sanofi, Food Allergy Research and Education, Regeneron Pharmaceuticals, Aimmune Therapeutics, UnitedHealth Group, National Confectioners Association, Astellas Pharma, National Institutes of Health, Genentech, National Heart, Lung, and Blood Institute, National Institute of Allergy and Infectious Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Environmental Health Sciences, National Center for Advancing Translational Sciences, Stanford Maternal and Child Health Research Institute
OpenAlex ID: W4291115869
FWCI: 0.901
Cites: 7
Cited by: 5
Related to: 10